{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:31:10Z","timestamp":1760549470495,"version":"3.40.4"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T00:00:00Z","timestamp":1389052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12272-013-0324-y","type":"journal-article","created":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T06:15:26Z","timestamp":1388988926000},"page":"285-298","source":"Crossref","is-referenced-by-count":6,"title":["Allosteric regulation of pathologic angiogenesis: potential application for angiogenesis-related blindness"],"prefix":"10.1007","volume":"37","author":[{"given":"Dong Hyun","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Ger","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,7]]},"reference":[{"key":"324_CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","volume":"118","author":"AP Adamis","year":"1994","unstructured":"Adamis, A.P., J.W. Miller, M.T. Bernal, D.J. D\u2019amico, J. Folkman, T.K. Yeo, and K.T. Yeo. 1994. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. American Journal of Ophthalmology 118: 445\u2013450.","journal-title":"American Journal of Ophthalmology"},{"key":"324_CR2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrm2183","volume":"8","author":"RH Adams","year":"2007","unstructured":"Adams, R.H., and K. Alitalo. 2007. Molecular regulation of angiogenesis and lymphangiogenesis. Nature Reviews Molecular Cell Biology 8: 464\u2013478.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"324_CR3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti, D.A., R. Klein, and T.W. Gardner. 2012. Diabetic retinopathy. New England Journal of Medicine 366: 1227\u20131239.","journal-title":"New England Journal of Medicine"},{"key":"324_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","volume":"97","author":"A Armulik","year":"2005","unstructured":"Armulik, A., A. Abramsson, and C. Betsholtz. 2005. Endothelial\/pericyte interactions. Circulation Research 97: 512\u2013523.","journal-title":"Circulation Research"},{"key":"324_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.cellbio.21.090704.151217","volume":"21","author":"MA Arnaout","year":"2005","unstructured":"Arnaout, M.A., B. Mahalingam, and J.P. Xiong. 2005. Integrin structure, allostery, and bidirectional signaling. Annual Review of Cell and Developmental Biology 21: 381\u2013410.","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"324_CR6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc2353","volume":"8","author":"CJ Avraamides","year":"2008","unstructured":"Avraamides, C.J., B. Garmy-Susini, and J.A. Varner. 2008. Integrins in angiogenesis and lymph angiogenesis. Nature Reviews Cancer 8: 604\u2013617.","journal-title":"Nature Reviews Cancer"},{"key":"324_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken, A., and M. Mohammadi. 2009. The FGF family: Biology, pathophysiology and therapy. Nature Reviews Drug Discovery 8: 235\u2013253.","journal-title":"Nature Reviews Drug Discovery"},{"key":"324_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","volume":"68","author":"RD Bell","year":"2010","unstructured":"Bell, R.D., E.A. Winkler, A.P. Sagare, I. Singh, B. Larue, R. Deane, and B.V. Zlokovic. 2010. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68: 409\u2013427.","journal-title":"Neuron"},{"key":"324_CR9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers, G., and S. Song. 2005. The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncology 7: 452\u2013464.","journal-title":"Neuro-Oncology"},{"key":"324_CR10","doi-asserted-by":"crossref","first-page":"29085","DOI":"10.1074\/jbc.M400930200","volume":"279","author":"V Binet","year":"2004","unstructured":"Binet, V., C. Brajon, L. Le Corre, F. Acher, J.P. Pin, and L. Prezeau. 2004. The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor. Journal of Biological Chemistry 279: 29085\u201329091.","journal-title":"Journal of Biological Chemistry"},{"key":"324_CR11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0026-895X(24)23041-8","volume":"55","author":"NJ Birdsall","year":"1999","unstructured":"Birdsall, N.J., T. Farries, P. Gharagozloo, S. Kobayashi, S. Lazareno, and M. Sugimoto. 1999. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: Functional studies. Molecular Pharmacology 55: 778\u2013786.","journal-title":"Molecular Pharmacology"},{"key":"324_CR12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrd1384","volume":"3","author":"B Booth","year":"2004","unstructured":"Booth, B., and R. Zemmel. 2004. Prospects for productivity. Nature Reviews Drug Discovery 3: 451\u2013456.","journal-title":"Nature Reviews Drug Discovery"},{"key":"324_CR13","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown, D.M., P.K. Kaiser, M. Michels, G. Soubrane, J.S. Heier, R.Y. Kim, J.P. Sy, and S. Schneider. 2006. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. New England Journal of Medicine 355: 1432\u20131444.","journal-title":"New England Journal of Medicine"},{"key":"324_CR14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajo.2012.04.020","volume":"154","author":"DJ Browning","year":"2012","unstructured":"Browning, D.J., P.K. Kaiser, P.J. Rosenfeld, and M.W. Stewart. 2012. Aflibercept for age-related macular degeneration: A game-changer or quiet addition? American Journal of Ophthalmology 154: 222\u2013226.","journal-title":"American Journal of Ophthalmology"},{"key":"324_CR15","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.bmc.2010.04.001","volume":"18","author":"A Buttner","year":"2010","unstructured":"Buttner, A., T. Cottin, J. Xu, L. Tzagkaroulaki, and A. Giannis. 2010. Serotonin derivatives as a new class of non-ATP-competitive receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry 18: 3387\u20133402.","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"324_CR16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/IAE.0b013e3182349686","volume":"32","author":"SH Byeon","year":"2012","unstructured":"Byeon, S.H., Y.K. Chu, Y.T. Hong, M. Kim, H.M. Kang, and O.W. Kwon. 2012. New insights into the pathoanatomy of diabetic macular edema: Angiographic patterns and optical coherence tomography. Retina 32: 1087\u20131099.","journal-title":"Retina"},{"key":"324_CR17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature 438: 932\u2013936.","journal-title":"Nature"},{"key":"324_CR18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet, P., and R.K. Jain. 2011. Molecular mechanisms and clinical applications of angiogenesis. Nature 473: 298\u2013307.","journal-title":"Nature"},{"key":"324_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-biophys-050511-102222","volume":"41","author":"JP Changeux","year":"2012","unstructured":"Changeux, J.P. 2012. Allostery and the Monod-Wyman-Changeux model after 50\u00a0years. Annual Review of Biophysics 41: 103\u2013133.","journal-title":"Annual Review of Biophysics"},{"key":"324_CR20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrclinonc.2009.94","volume":"6","author":"HX Chen","year":"2009","unstructured":"Chen, H.X., and J.N. Cleck. 2009. Adverse effects of anticancer agents that target the VEGF pathway. Nature Reviews. Clinical Oncology 6: 465\u2013477.","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"324_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MOP.0b013e3283423f35","volume":"23","author":"J Chen","year":"2011","unstructured":"Chen, J., A. Stahl, A. Hellstrom, and L.E. Smith. 2011. Current update on retinopathy of prematurity: Screening and treatment. Current Opinion in Pediatrics 23: 173\u2013178.","journal-title":"Current Opinion in Pediatrics"},{"key":"324_CR22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","volume":"1","author":"A Christopoulos","year":"2002","unstructured":"Christopoulos, A. 2002. Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery. Nature Reviews Drug Discovery 1: 198\u2013210.","journal-title":"Nature Reviews Drug Discovery"},{"key":"324_CR23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","volume":"112","author":"TE Clemons","year":"2005","unstructured":"Clemons, T.E., R.C. Milton, R. Klein, J.M. Seddon, and F.L. Ferris 3rd. 2005. Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology 112: 533\u2013539.","journal-title":"Ophthalmology"},{"key":"324_CR24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","volume":"122","author":"N Congdon","year":"2004","unstructured":"Congdon, N., B. O\u2019colmain, C.C. Klaver, R. Klein, B. Munoz, D.S. Friedman, J. Kempen, H.R. Taylor, and P. Mitchell. 2004. Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology 122: 477\u2013485.","journal-title":"Archives of Ophthalmology"},{"key":"324_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","volume":"8","author":"PJ Conn","year":"2009","unstructured":"Conn, P.J., A. Christopoulos, and C.W. Lindsley. 2009. Allosteric modulators of GPCRs: A novel approach for the treatment of CNS disorders. Nature Reviews Drug Discovery 8: 41\u201354.","journal-title":"Nature Reviews Drug Discovery"},{"key":"324_CR26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00276625","volume":"11","author":"A Cooper","year":"1984","unstructured":"Cooper, A., and D.T. Dryden. 1984. Allostery without conformational change. A plausible model. European Biophysics Journal 11: 103\u2013109.","journal-title":"European Biophysics Journal"},{"key":"324_CR27","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMra062326","volume":"355","author":"PT Jong De","year":"2006","unstructured":"De Jong, P.T. 2006. Age-related macular degeneration. New England Journal of Medicine 355: 1474\u20131485.","journal-title":"New England Journal of Medicine"},{"key":"324_CR28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.str.2009.06.008","volume":"17","author":"A Sol Del","year":"2009","unstructured":"Del Sol, A., C.J. Tsai, B. Ma, and R. Nussinov. 2009. The origin of allosteric functional modulation: Multiple pre-existing pathways. Structure 17: 1042\u20131050.","journal-title":"Structure"},{"key":"324_CR29","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1517\/13543784.2010.524204","volume":"19","author":"MH Fens","year":"2010","unstructured":"Fens, M.H., G. Storm, and R.M. Schiffelers. 2010. Tumor vasculature as target for therapeutic intervention. Expert Opinion on Investigational Drugs 19: 1321\u20131338.","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"324_CR30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1684\/ecn.2009.0170","volume":"20","author":"N Ferrara","year":"2009","unstructured":"Ferrara, N. 2009. VEGF-A: A critical regulator of blood vessel growth. European Cytokine Network 20: 158\u2013163.","journal-title":"European Cytokine Network"},{"key":"324_CR31","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1074\/jbc.M710025200","volume":"283","author":"LR Fiedler","year":"2008","unstructured":"Fiedler, L.R., E. Schonherr, R. Waddington, S. Niland, D.G. Seidler, D. Aeschlimann, and J.A. Eble. 2008. Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. Journal of Biological Chemistry 283: 17406\u201317415.","journal-title":"Journal of Biological Chemistry"},{"key":"324_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra021678","volume":"350","author":"RN Frank","year":"2004","unstructured":"Frank, R.N. 2004. Diabetic retinopathy. New England Journal of Medicine 350: 48\u201358.","journal-title":"New England Journal of Medicine"},{"key":"324_CR33","doi-asserted-by":"crossref","first-page":"11197","DOI":"10.1074\/jbc.273.18.11197","volume":"273","author":"G Fuh","year":"1998","unstructured":"Fuh, G., B. Li, C. Crowley, B. Cunningham, and J.A. Wells. 1998. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. Journal of Biological Chemistry 273: 11197\u201311204.","journal-title":"Journal of Biological Chemistry"},{"key":"324_CR34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/07853890600946724","volume":"38","author":"KM Gehrs","year":"2006","unstructured":"Gehrs, K.M., D.H. Anderson, L.V. Johnson, and G.S. Hageman. 2006. Age-related macular degeneration\u2013emerging pathogenetic and therapeutic concepts. Annals of Medicine 38: 450\u2013471.","journal-title":"Annals of Medicine"},{"key":"324_CR35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/02713680802585946","volume":"34","author":"B George","year":"2009","unstructured":"George, B., S. Chen, V. Chaudhary, J. Gonder, and S. Chakrabarti. 2009. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy. Current Eye Research 34: 134\u2013144.","journal-title":"Current Eye Research"},{"key":"324_CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.2004-1413","volume":"116","author":"WV Good","year":"2005","unstructured":"Good, W.V., R.J. Hardy, V. Dobson, E.A. Palmer, D.L. Phelps, M. Quintos, and B. Tung. 2005. The incidence and course of retinopathy of prematurity: Findings from the early treatment for retinopathy of prematurity study. Pediatrics 116: 15\u201323.","journal-title":"Pediatrics"},{"key":"324_CR37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nchembio.98","volume":"4","author":"NM Goodey","year":"2008","unstructured":"Goodey, N.M., and S.J. Benkovic. 2008. Allosteric regulation and catalysis emerge via a common route. Nature Chemical Biology 4: 474\u2013482.","journal-title":"Nature Chemical Biology"},{"key":"324_CR38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuropharm.2010.07.007","volume":"60","author":"KJ Gregory","year":"2011","unstructured":"Gregory, K.J., E.N. Dong, J. Meiler, and P.J. Conn. 2011. Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential. Neuropharmacology 60: 66\u201381.","journal-title":"Neuropharmacology"},{"key":"324_CR39","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/cbic.200800528","volume":"9","author":"P Hauske","year":"2008","unstructured":"Hauske, P., C. Ottmann, M. Meltzer, M. Ehrmann, and M. Kaiser. 2008. Allosteric regulation of proteases. ChemBioChem 9: 2920\u20132928.","journal-title":"ChemBioChem"},{"key":"324_CR40","doi-asserted-by":"crossref","first-page":"e33456","DOI":"10.1371\/journal.pone.0033456","volume":"7","author":"JW Heo","year":"2012","unstructured":"Heo, J.W., J.H. Kim, C.S. Cho, H.O. Jun, D.H. Kim, and Y.S. Yu. 2012. Inhibitory activity of bevacizumab to differentiation of retinoblastoma cells. PLoS ONE 7: e33456.","journal-title":"PLoS ONE"},{"key":"324_CR41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-biophys-050511-102319","volume":"41","author":"VJ Hilser","year":"2012","unstructured":"Hilser, V.J., J.O. Wrabl, and H.N. Motlagh. 2012. Structural and energetic basis of allostery. Annual Review of Biophysics 41: 585\u2013609.","journal-title":"Annual Review of Biophysics"},{"key":"324_CR42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben, A., B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, and E.A. De Bruijn. 2004. Vascular endothelial growth factor and angiogenesis. Pharmacological Reviews 56: 549\u2013580.","journal-title":"Pharmacological Reviews"},{"key":"324_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000280386","volume":"98","author":"A Hoogerwerf","year":"2010","unstructured":"Hoogerwerf, A., N.E. Schalij-Delfos, M.J. Van Schooneveld, and J.U. Termote. 2010. Incidence of retinopathy of prematurity over the last decade in the Central Netherlands. Neonatology 98: 137\u2013142.","journal-title":"Neonatology"},{"key":"324_CR44","doi-asserted-by":"crossref","first-page":"D663","DOI":"10.1093\/nar\/gkq1022","volume":"39","author":"Z Huang","year":"2011","unstructured":"Huang, Z., L. Zhu, Y. Cao, G. Wu, X. Liu, Y. Chen, Q. Wang, T. Shi, Y. Zhao, Y. Wang, W. Li, Y. Li, H. Chen, G. Chen, and J. Zhang. 2011. ASD: A comprehensive database of allosteric proteins and modulators. Nucleic Acids Research 39: D663\u2013D669.","journal-title":"Nucleic Acids Research"},{"key":"324_CR45","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1128\/MCB.06787-11","volume":"32","author":"CA Hyde","year":"2012","unstructured":"Hyde, C.A., A. Giese, E. Stuttfeld, J. Abram Saliba, D. Villemagne, T. Schleier, H.K. Binz, and K. Ballmer-Hofer. 2012. Targeting extracellular domains d4 and d7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites. Molecular and Cellular Biology 32: 3802\u20133813.","journal-title":"Molecular and Cellular Biology"},{"key":"324_CR46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes, R.O. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673\u2013687.","journal-title":"Cell"},{"key":"324_CR47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archophthalmol.2012.1043","volume":"130","author":"MS Ip","year":"2012","unstructured":"Ip, M.S., A. Domalpally, J.J. Hopkins, P. Wong, and J.S. Ehrlich. 2012. Long-term effects of Ranibizumab on diabetic retinopathy severity and progression. Archives of Ophthalmology 130: 1145\u20131152.","journal-title":"Archives of Ophthalmology"},{"key":"324_CR48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain, R.K. 2005. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307: 58\u201362.","journal-title":"Science"},{"key":"324_CR49","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s12272-010-1007-6","volume":"33","author":"DH Jo","year":"2010","unstructured":"Jo, D.H., J.H. Kim, and J.H. Kim. 2010. How to overcome retinal neuropathy: The fight against angiogenesis-related blindness. Archives of Pharmacal Research 33: 1557\u20131565.","journal-title":"Archives of Pharmacal Research"},{"key":"324_CR50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/187152212800389012","volume":"12","author":"DH Jo","year":"2012","unstructured":"Jo, D.H., J.H. Kim, and J.H. Kim. 2012. How to overcome diabetic retinopathy: Focusing on blood-retinal barrier. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry 12: 110\u2013117.","journal-title":"Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry"},{"key":"324_CR51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000102935","volume":"39","author":"JB Jonas","year":"2007","unstructured":"Jonas, J.B., and M. Neumaier. 2007. Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema. Ophthalmic Research 39: 139\u2013142.","journal-title":"Ophthalmic Research"},{"key":"324_CR52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archopht.122.4.552","volume":"122","author":"JH Kempen","year":"2004","unstructured":"Kempen, J.H., B.J. O\u2019colmain, M.C. Leske, S.M. Haffner, R. Klein, S.E. Moss, H.R. Taylor, R.F. Hamman, and Eye Diseases Prevalence Research, G. 2004. The prevalence of diabetic retinopathy among adults in the United States. Archives of Ophthalmology 122: 552\u2013563.","journal-title":"Archives of Ophthalmology"},{"key":"324_CR53","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrd1875","volume":"4","author":"T Kenakin","year":"2005","unstructured":"Kenakin, T. 2005. New concepts in drug discovery: Collateral efficacy and permissive antagonism. Nature Reviews Drug Discovery 4: 919\u2013927.","journal-title":"Nature Reviews Drug Discovery"},{"key":"324_CR54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2010.07.010","volume":"60","author":"P Keov","year":"2011","unstructured":"Keov, P., P.M. Sexton, and A. Christopoulos. 2011. Allosteric modulation of G protein-coupled receptors: A pharmacological perspective. Neuropharmacology 60: 24\u201335.","journal-title":"Neuropharmacology"},{"key":"324_CR55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10456-005-9017-6","volume":"8","author":"ZA Khan","year":"2005","unstructured":"Khan, Z.A., B.M. Chan, S. Uniyal, Y.P. Barbin, H. Farhangkhoee, S. Chen, and S. Chakrabarti. 2005. EDB fibronectin and angiogenesis: A novel mechanistic pathway. Angiogenesis 8: 183\u2013196.","journal-title":"Angiogenesis"},{"key":"324_CR56","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/jcbfm.2009.78","volume":"29","author":"JH Kim","year":"2009","unstructured":"Kim, J.H., Y.M. Lee, E.M. Ahn, K.W. Kim, and Y.S. Yu. 2009. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. Journal of Cerebral Blood Flow and Metabolism 29: 1559\u20131567.","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"324_CR57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archophthalmol.2010.318","volume":"129","author":"R Klein","year":"2011","unstructured":"Klein, R., C.F. Chou, B.E. Klein, X. Zhang, S.M. Meuer, and J.B. Saaddine. 2011. Prevalence of age-related macular degeneration in the US population. Archives of Ophthalmology 129: 75\u201380.","journal-title":"Archives of Ophthalmology"},{"key":"324_CR58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1073\/pnas.44.2.98","volume":"44","author":"DE Koshland","year":"1958","unstructured":"Koshland, D.E. 1958. Application of a theory of enzyme specificity to protein synthesis. Proceedings of the National Academy of Sciences of the United States of America 44: 98\u2013104.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"324_CR59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcp.1030540420","volume":"54","author":"DE Koshland Jr","year":"1959","unstructured":"Koshland Jr, D.E. 1959. Enzyme flexibility and enzyme action. Journal of Cellular and Comparative Physiology 54: 245\u2013258.","journal-title":"Journal of Cellular and Comparative Physiology"},{"key":"324_CR60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajo.2009.04.018","volume":"148","author":"EM Lad","year":"2009","unstructured":"Lad, E.M., T. Hernandez-Boussard, J.M. Morton, and D.M. Moshfeghi. 2009. Incidence of retinopathy of prematurity in the United States: 1997 Through 2005. American Journal of Ophthalmology 148: 451\u2013458.","journal-title":"American Journal of Ophthalmology"},{"key":"324_CR61","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/mol.53.3.573","volume":"53","author":"S Lazareno","year":"1998","unstructured":"Lazareno, S., P. Gharagozloo, D. Kuonen, A. Popham, and N.J. Birdsall. 1998. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: Radioligand binding studies. Molecular Pharmacology 53: 573\u2013589.","journal-title":"Molecular Pharmacology"},{"key":"324_CR62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1124\/mol.65.1.257","volume":"65","author":"S Lazareno","year":"2004","unstructured":"Lazareno, S., V. Dolezal, A. Popham, and N.J. Birdsall. 2004. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: Receptor subtype selectivity via cooperativity rather than affinity. Molecular Pharmacology 65: 257\u2013266.","journal-title":"Molecular Pharmacology"},{"key":"324_CR63","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/eye.2012.111","volume":"26","author":"BJ Lee","year":"2012","unstructured":"Lee, B.J., J.H. Kim, H. Heo, and Y.S. Yu. 2012. Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye (Lond) 26: 903\u2013909.","journal-title":"Eye (Lond)"},{"key":"324_CR64","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1158\/1535-7163.MCT-11-0738","volume":"11","author":"S Liekens","year":"2012","unstructured":"Liekens, S., A. Bronckaers, M. Belleri, A. Bugatti, R. Sienaert, D. Ribatti, B. Nico, A. Gigante, E. Casanova, G. Opdenakker, M.J. Perez-Perez, J. Balzarini, and M. Presta. 2012. The thymidine phosphorylase inhibitor 5\u2032-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist. Molecular Cancer Therapeutics 11: 817\u2013829.","journal-title":"Molecular Cancer Therapeutics"},{"key":"324_CR65","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim, L.S., P. Mitchell, J.M. Seddon, F.G. Holz, and T.Y. Wong. 2012a. Age-related macular degeneration. Lancet 379: 1728\u20131738.","journal-title":"Lancet"},{"key":"324_CR66","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2337\/db11-1541","volume":"61","author":"Y Lim","year":"2012","unstructured":"Lim, Y., D.H. Jo, J.H. Kim, J.H. Ahn, Y.K. Hwang, D.K. Kang, S.I. Chang, Y.S. Yu, and Y. Yoon. 2012b. Human apolipoprotein(a) kringle V inhibits ischemia-induced retinal neovascularization via suppression of fibronectin-mediated angiogenesis. Diabetes 61: 1599\u20131608.","journal-title":"Diabetes"},{"key":"324_CR67","first-page":"855","volume":"37","author":"PF Lopez","year":"1996","unstructured":"Lopez, P.F., B.D. Sippy, H.M. Lambert, A.B. Thach, and D.R. Hinton. 1996. Trans differentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Investigative Ophthalmology & Visual Science 37: 855\u2013868.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"324_CR68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/bjophthalmol-2011-301087","volume":"96","author":"K Manousaridis","year":"2012","unstructured":"Manousaridis, K., and J. Talks. 2012. Macular ischaemia: A contraindication for anti-VEGF treatment in retinal vascular disease? British Journal of Ophthalmology 96: 179\u2013184.","journal-title":"British Journal of Ophthalmology"},{"key":"324_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105159","volume":"47","author":"LT May","year":"2007","unstructured":"May, L.T., K. Leach, P.M. Sexton, and A. Christopoulos. 2007. Allosteric modulation of G protein-coupled receptors. Annual Review of Pharmacology and Toxicology 47: 1\u201351.","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"324_CR70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","volume":"120","author":"JW Miller","year":"2012","unstructured":"Miller, J.W., J. Le Couter, E.C. Strauss, and N. Ferrara. 2012. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 120: 106\u2013114.","journal-title":"Ophthalmology"},{"key":"324_CR71","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner, H.A., K.A. Kennedy, and A.Z. Chuang. 2011. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. New England Journal of Medicine 364: 603\u2013615.","journal-title":"New England Journal of Medicine"},{"key":"324_CR72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","volume":"16","author":"M Mohammadi","year":"2005","unstructured":"Mohammadi, M., S.K. Olsen, and O.A. Ibrahimi. 2005. Structural basis for fibroblast growth factor receptor activation. Cytokine & Growth Factor Reviews 16: 107\u2013137.","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"324_CR73","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-2836(63)80091-1","volume":"6","author":"J Monod","year":"1963","unstructured":"Monod, J., J.P. Changeux, and F. Jacob. 1963. Allosteric proteins and cellular control systems. Journal of Molecular Biology 6: 306\u2013329.","journal-title":"Journal of Molecular Biology"},{"key":"324_CR74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-2836(65)80285-6","volume":"12","author":"J Monod","year":"1965","unstructured":"Monod, J., J. Wyman, and J.P. Changeux. 1965. On the nature of allosteric transitions: A plausible model. Journal of Molecular Biology 12: 88\u2013118.","journal-title":"Journal of Molecular Biology"},{"key":"324_CR75","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1172\/JCI44762","volume":"121","author":"M Murakami","year":"2011","unstructured":"Murakami, M., L.T. Nguyen, K. Hatanaka, W. Schachterle, P.Y. Chen, Z.W. Zhuang, B.L. Black, and M. Simons. 2011. FGF-dependent regulation of VEGF receptor 2 expression in mice. The Journal of Clinical Investigation 121: 2668\u20132678.","journal-title":"The Journal of Clinical Investigation"},{"key":"324_CR76","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI35298","volume":"118","author":"M Murakami","year":"2008","unstructured":"Murakami, M., L.T. Nguyen, Z.W. Zhuang, K.L. Moodie, P. Carmeliet, R.V. Stan, and M. Simons. 2008. The FGF system has a key role in regulating vascular integrity. The Journal of Clinical Investigation 118: 3355\u20133366.","journal-title":"The Journal of Clinical Investigation"},{"key":"324_CR77","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.pathol.2.010506.134925","volume":"2","author":"JA Nagy","year":"2007","unstructured":"Nagy, J.A., A.M. Dvorak, and H.F. Dvorak. 2007. VEGF-A and the induction of pathological angiogenesis. Annual Review of Pathology: Mechanisms of Disease 2: 251\u2013275.","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"324_CR78","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen, Q.D., D.M. Brown, D.M. Marcus, D.S. Boyer, S. Patel, L. Feiner, A. Gibson, J. Sy, A.C. Rundle, J.J. Hopkins, R.G. Rubio, and J.S. Ehrlich. 2012. Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119: 789\u2013801.","journal-title":"Ophthalmology"},{"key":"324_CR79","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bjo.2005.066431","volume":"89","author":"QD Nguyen","year":"2005","unstructured":"Nguyen, Q.D., S. Shah, S. Tatlipinar, D.V. Do, E.V. Anden, and P.A. Campochiaro. 2005. Bevacizumab suppresses choroidal neovascularization caused by pathological myopia. British Journal of Ophthalmology 89: 1368\u20131370.","journal-title":"British Journal of Ophthalmology"},{"key":"324_CR80","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/emboj.2010.30","volume":"29","author":"I Nilsson","year":"2010","unstructured":"Nilsson, I., F. Bahram, X. Li, L. Gualandi, S. Koch, M. Jarvius, O. Soderberg, A. Anisimov, I. Kholova, B. Pytowski, M. Baldwin, S. Yla-Herttuala, K. Alitalo, J. Kreuger, and L. Claesson-Welsh. 2010. VEGF receptor 2\/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO Journal 29: 1377\u20131388.","journal-title":"EMBO Journal"},{"key":"324_CR81","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3129\/i08-145","volume":"43","author":"A Ning","year":"2008","unstructured":"Ning, A., J. Cui, D. Maberley, P. Ma, and J. Matsubara. 2008. Expression of integrins in human proliferative diabetic retinopathy membranes. Canadian Journal of Ophthalmology 43: 683\u2013688.","journal-title":"Canadian Journal of Ophthalmology"},{"key":"324_CR82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima, K., Y.S. Ng, L. Zhong, J. Bradley, W. Schubert, N. Jo, J. Akita, S.J. Samuelsson, G.S. Robinson, A.P. Adamis, and D.T. Shima. 2007. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. American Journal of Pathology 171: 53\u201367.","journal-title":"American Journal of Pathology"},{"key":"324_CR83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/MCB.12.1.240","volume":"12","author":"DM Ornitz","year":"1992","unstructured":"Ornitz, D.M., A. Yayon, J.G. Flanagan, C.M. Svahn, E. Levi, and P. Leder. 1992. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Molecular and Cellular Biology 12: 240\u2013247.","journal-title":"Molecular and Cellular Biology"},{"key":"324_CR84","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","volume":"98","author":"EA Palmer","year":"1991","unstructured":"Palmer, E.A., J.T. Flynn, R.J. Hardy, D.L. Phelps, C.L. Phillips, D.B. Schaffer, and B. Tung. 1991. Incidence and early course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group. Ophthalmology 98: 1628\u20131640.","journal-title":"Ophthalmology"},{"key":"324_CR85","first-page":"801","volume":"130","author":"RD Patel","year":"2012","unstructured":"Patel, R.D., M.P. Blair, M.J. Shapiro, and S.J. Lichtenstein. 2012. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Archives of Ophthalmology 130: 801\u2013802.","journal-title":"Archives of Ophthalmology"},{"key":"324_CR86","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbapap.2010.10.008","volume":"1814","author":"A Peracchi","year":"2011","unstructured":"Peracchi, A., and A. Mozzarelli. 2011. Exploring and exploiting allostery: Models, evolution, and drug targeting. Biochimica et Biophysica Acta 1814: 922\u2013933.","journal-title":"Biochimica et Biophysica Acta"},{"key":"324_CR87","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nsmb1132","volume":"13","author":"N Popovych","year":"2006","unstructured":"Popovych, N., S. Sun, R.H. Ebright, and C.G. Kalodimos. 2006. Dynamically driven protein allostery. Nature Structural & Molecular Biology 13: 831\u2013838.","journal-title":"Nature Structural & Molecular Biology"},{"key":"324_CR88","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","volume":"146","author":"M Potente","year":"2011","unstructured":"Potente, M., H. Gerhardt, and P. Carmeliet. 2011. Basic and therapeutic aspects of angiogenesis. Cell 146: 873\u2013887.","journal-title":"Cell"},{"key":"324_CR89","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.preteyeres.2008.11.005","volume":"28","author":"EB Rodrigues","year":"2009","unstructured":"Rodrigues, E.B., M.E. Farah, M. Maia, F.M. Penha, C. Regatieri, G.B. Melo, M.M. Pinheiro, and C.R. Zanetti. 2009. Therapeutic monoclonal antibodies in ophthalmology. Progress in Retinal and Eye Research 28: 117\u2013144.","journal-title":"Progress in Retinal and Eye Research"},{"key":"324_CR90","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld, P.J., D.M. Brown, J.S. Heier, D.S. Boyer, P.K. Kaiser, C.Y. Chung, and R.Y. Kim. 2006. Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine 355: 1419\u20131431.","journal-title":"New England Journal of Medicine"},{"key":"324_CR91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2008.07.121","volume":"375","author":"R Roskoski Jr","year":"2008","unstructured":"Roskoski Jr, R. 2008. VEGF receptor protein-tyrosine kinases: Structure and regulation. Biochemical and Biophysical Research Communications 375: 287\u2013291.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"324_CR92","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1172\/JCI42142","volume":"120","author":"P Sapieha","year":"2010","unstructured":"Sapieha, P., J.S. Joyal, J.C. Rivera, E. Kermorvant-Duchemin, F. Sennlaub, P. Hardy, P. Lachapelle, and S. Chemtob. 2010. Retinopathy of prematurity: Understanding ischemic retinal vasculopathies at an extreme of life. The Journal of Clinical Investigation 120: 3022\u20133032.","journal-title":"The Journal of Clinical Investigation"},{"key":"324_CR93","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","volume":"116","author":"T Sato","year":"2009","unstructured":"Sato, T., S. Kusaka, H. Shimojo, and T. Fujikado. 2009. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 116: 1599\u20131603.","journal-title":"Ophthalmology"},{"key":"324_CR94","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","volume":"103","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103: 211\u2013225.","journal-title":"Cell"},{"key":"324_CR95","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","volume":"6","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger, J., A.N. Plotnikov, O.A. Ibrahimi, A.V. Eliseenkova, B.K. Yeh, A. Yayon, R.J. Linhardt, and M. Mohammadi. 2000. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Molecular Cell 6: 743\u2013750.","journal-title":"Molecular Cell"},{"key":"324_CR96","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/ATVBAHA.108.172015","volume":"28","author":"R Silva","year":"2008","unstructured":"Silva, R., G. D\u2019amico, K.M. Hodivala-Dilke, and L.E. Reynolds. 2008. Integrins: The keys to unlocking angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 1703\u20131713.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"324_CR97","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1167\/iovs.12-9732","volume":"53","author":"S Tewari","year":"2012","unstructured":"Tewari, S., Q. Zhong, J.M. Santos, and R.A. Kowluru. 2012. Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy. Investigative Ophthalmology & Visual Science 53: 4881\u20134888.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"324_CR98","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329: 977\u2013986.","journal-title":"New England Journal of Medicine"},{"key":"324_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2008.02.034","volume":"378","author":"CJ Tsai","year":"2008","unstructured":"Tsai, C.J., A. Del Sol, and R. Nussinov. 2008. Allostery: Absence of a change in shape does not imply that allostery is not at play. Journal of Molecular Biology 378: 1\u201311.","journal-title":"Journal of Molecular Biology"},{"key":"324_CR100","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1016\/j.bmc.2008.05.015","volume":"16","author":"DG Udugamasooriya","year":"2008","unstructured":"Udugamasooriya, D.G., C. Ritchie, R.A. Brekken, and T. Kodadek. 2008a. A peptoid antagonist of VEGF receptor 2 recognizes a \u2018hotspot\u2019 in the extracellular domain distinct from the hormone-binding site. Bioorganic and Medicinal Chemistry 16: 6338\u20136343.","journal-title":"Bioorganic and Medicinal Chemistry"},{"key":"324_CR101","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1021\/ja711193x","volume":"130","author":"DG Udugamasooriya","year":"2008","unstructured":"Udugamasooriya, D.G., S.P. Dineen, R.A. Brekken, and T. Kodadek. 2008b. A peptoid \u201cantibody surrogate\u201d that antagonizes VEGF receptor 2 activity. Journal of the American Chemical Society 130: 5744\u20135752.","journal-title":"Journal of the American Chemical Society"},{"key":"324_CR102","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","unstructured":"UK Prospective Diabetes Study Group. 1998. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703\u2013713.","journal-title":"BMJ"},{"key":"324_CR103","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","volume":"269","author":"J Waltenberger","year":"1994","unstructured":"Waltenberger, J., L. Claesson-Welsh, A. Siegbahn, M. Shibuya, and C.H. Heldin. 1994. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. Journal of Biological Chemistry 269: 26988\u201326995.","journal-title":"Journal of Biological Chemistry"},{"key":"324_CR104","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/prot.22223","volume":"75","author":"TR Weikl","year":"2009","unstructured":"Weikl, T.R., and C. Von Deuster. 2009. Selected-fit versus induced-fit protein binding: Kinetic differences and mutational analysis. Proteins 75: 104\u2013110.","journal-title":"Proteins"},{"key":"324_CR105","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archopht.126.12.1707","volume":"126","author":"NH White","year":"2008","unstructured":"White, N.H., W. Sun, P.A. Cleary, R.P. Danis, M.D. Davis, D.P. Hainsworth, L.D. Hubbard, J.M. Lachin, and D.M. Nathan. 2008. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10\u00a0years after the diabetes control and complications trial. Archives of Ophthalmology 126: 1707\u20131715.","journal-title":"Archives of Ophthalmology"},{"key":"324_CR106","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1016\/j.bmcl.2006.04.037","volume":"16","author":"H Yin","year":"2006","unstructured":"Yin, H., L.O. Gerlach, M.W. Miller, D.T. Moore, D. Liu, G. Vilaire, J.S. Bennett, and W.F. Degrado. 2006. Arylamide derivatives as allosteric inhibitors of the integrin alpha2 beta1\/type I collagen interaction. Bioorganic & Medicinal Chemistry Letters 16: 3380\u20133382.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"324_CR107","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd3745","volume":"11","author":"K Zhang","year":"2012","unstructured":"Zhang, K., L. Zhang, and R.N. Weinreb. 2012. Ophthalmic drug discovery: Novel targets and mechanisms for retinal diseases and glaucoma. Nature Reviews Drug Discovery 11: 541\u2013559.","journal-title":"Nature Reviews Drug Discovery"},{"key":"324_CR108","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/db10-0133","volume":"60","author":"Q Zhong","year":"2011","unstructured":"Zhong, Q., and R.A. Kowluru. 2011. Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes 60: 1304\u20131313.","journal-title":"Diabetes"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-013-0324-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-013-0324-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-013-0324-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:13:32Z","timestamp":1746098012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-013-0324-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,7]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1007\/s12272-013-0324-y","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"type":"print","value":"0253-6269"},{"type":"electronic","value":"1976-3786"}],"subject":[],"published":{"date-parts":[[2014,1,7]]}}}